← Back to headlines
Mizuho Maintains Outperform Rating on Insmed Incorporated
Mizuho Securities has reiterated its 'Outperform' rating for Insmed Incorporated (INSM), signaling continued confidence in the pharmaceutical company's stock performance.
28 Jun, 20:07 — 28 Jun, 20:07
Sources
Showing 1 of 1 sources
Related Stories
Canada Imposes Retaliatory Tariffs on US Goods Amid Trade Dispute
13m ago
Indonesia Targets 100 GW Solar Power Capacity and End to Fossil Fuel Imports
22m ago
Households and Corporates Positioned for Higher Yields Amid Rising Interest Rate Expectations
42m ago
New European Standards for Drinking Water Contact Materials Effective 2026
44m ago